期刊名称：BORDERLINE PERSONALITY DISORDER AND EMOTION DYSREGULATION
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Aims and scope
Borderline Personality Disorder and Emotion Dysregulation provides a platform for researchers and clinicians interested in borderline personality disorder (BPD) as a currently highly challenging psychiatric disorder. Emotion dysregulation is at the core of BPD but also stands on its own as a major pathological component of the underlying neurobiology of various other psychiatric disorders. The journal focuses on the psychological, social and neurobiological aspects of emotion dysregulation as well as epidemiology, phenomenology, pathophysiology, treatment, neurobiology, genetics, and animal models of BPD. Contributions investigating the broad field of emotion regulation and dysregulation as well as related pathological mechanisms such as dysfunctional self-concepts and dysfunctional social interaction are welcomed, as are studies of novel treatments for BPD. In addition, the journal considers research into the frequent, co-occurring psychiatric disorders like Post-traumatic Stress Disorder, ADHD, depression, eating disorders, conduct disorders, drug abuse, and social phobia.
Open access
All articles published by Borderline Personality Disorder and Emotion Dysregulation are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.
As authors of articles published in Borderline Personality Disorder and Emotion Dysregulationyou are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the BMC license agreement.
For those of you who are US government employees or are prevented from being copyright holders for similar reasons, BMC can accommodate non-standard copyright lines. Please contact us if further information is needed.
Article-processing charges
Open access publishing is not without costs. Borderline Personality Disorder and Emotion Dysregulation therefore levies an article-processing charge of £1370.00/$2145.00/€1745.00 for each article accepted for publication, plus VAT or local taxes where applicable.
If the corresponding author's institution participates in our open access membership program, some or all of the publication cost may be covered (more details available on the membership page). We routinely waive charges for authors from low-income countries.
For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, including how to request a waiver or discount, see our article-processing charge page.
BMC provides a free open access funding support service to help authors discover and apply for article processing charge funding. Visit our OA funding and policy support page to view our list of research funders and institutions that provide funding for APCs, and to learn more about our email support service.
Indexing services
All articles published in Borderline Personality Disorder and Emotion Dysregulation are included in PubMed, PubMed Central and DOAJ. The journal has also been accepted into Scopus and Web of Science (Science Citation Index Expanded).
The full text of all articles is deposited in digital archives around the world to guarantee long-term digital preservation. You can also access all articles published by BioMed Central on SpringerLink.
We are working closely with relevant indexing services to ensure that articles published in Borderline Personality Disorder and Emotion Dysregulation will be available in their databases when appropriate.
Peer-review policy
Peer-review is the system used to assess the quality of a manuscript before it is published. Independent researchers in the relevant research area assess submitted manuscripts for originality, validity and significance to help editors determine whether the manuscript should be published in their journal. You can read more about the peer-review process here.
Borderline Personality Disorder and Emotion Dysregulation operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous.
The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.
Submitted manuscripts will generally be reviewed by two or more experts who will be asked to evaluate whether the manuscript is scientifically sound and coherent, whether it duplicates already published work, and whether or not the manuscript is sufficiently clear for publication. The Editor-in-Chief and Section Editors will reach a decision based on these reports and, where necessary, they will consult with members of the Editorial Board.
Instructions to Authors
Our 3-step submission process
-
Before you submit
Now you’ve identified a journal to submit to, there are a few things you should be familiar with before you submit.
-
Ready to submit
To give your manuscript the best chance of publication, follow these policies and formatting guidelines.
-
Submit and promote
After acceptance, we provide support so your article gains maximum impact in the scientific community and beyond.
Please note that manuscript can only be submitted by an author of the manuscript and may not be submitted by a third party.
Submit manuscript
Editorial Board
Editors-in-Chief
Martin Bohus, Central Institute of Mental Health, Germany
John Oldham, Baylor College of Medicine, USA
Christian Schmahl, Central Institute of Mental Health, Germany
Section Editors
Annegret Krause-Utz, Leiden University, The Netherlands
Alexandra Philipsen, University Hospital Bonn, Germany
Carla Sharp, University of Houston, USA
Ulrich Voderholzer, Ludwig Maximilians University of Munich, Germany
Editorial Board
Arnoud AA Arntz, University of Amsterdam, Netherlands
Anthony Bateman, University College London, UK
Andrew Chanen, University of Melbourne, Australia
Alexander Chapman, Simon Fraser University, Canada
Eunice Chen, University of Chicago, USA
Emil Coccaro, University of Chicago, USA
Ulrich Ebner-Priemer, Karlsruhe Institute of Technology, Germany
Thomas Elbert, University of Konstanz, Germany
Bernet M Elzinga, Leiden University, The Netherlands
Andreas J Fallgatter, Eberhard Karls University of Tübingen, Germany
Herta Flor, Central Institute of Mental Health, Germany
Azucena Garcia-Palacios, Jaume I University, Spain
James J Gross, Stanford University, USA
John G Gunderson, Harvard University, USA
Markus Heinrichs, University of Freiburg, Germany
Andreas Heinz, Humboldt University, Germany
Sabine Herpertz, Heidelberg University, Germany
Nikolaus Kleindienst, Central Institute of Mental Health, Germany
Harold Koenigsberg, Mount Sinai School of Medicine, USA
Klaus Lieb, Mainz University Medical Center, Germany
Marsha Linehan, University of Washington, USA
Paul Links, University of Western Ontario, Canada
Shelley McMain, Center for Addiction and Mental Health, Canada
Lars Mehlum, University of Oslo, Norway
Andreas Meyer-Lindenberg, Central Institute of Mental Health, Germany
Les Morey, Texas A&M University, USA
Antonia New, Mount Sinai School of Medicine, USA
Maria Oquendo, Columbia University, USA
K Luan Phan, University of Illinois at Chicago, USA
Marcella Rietschel, Central Institute of Mental Health, Germany
Ulrich Schweiger, University of Lübeck, Germany
Erich Seifritz, University of Zurich, Switzerland
Andrew E Skodol, University of Arizona, USA
Chun Wang, Nanjing Medical University, China
Mary C Zanarini, Harvard University, USA
Jon-Kar Zubieta, University of Michigan, USA
|
